GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » EV-to-FCF

Chordate Medical Holding AB (OSTO:CMH) EV-to-FCF : -0.80 (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Chordate Medical Holding AB's Enterprise Value is kr22.78 Mil. Chordate Medical Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was kr-28.41 Mil. Therefore, Chordate Medical Holding AB's EV-to-FCF for today is -0.80.

The historical rank and industry rank for Chordate Medical Holding AB's EV-to-FCF or its related term are showing as below:

OSTO:CMH' s EV-to-FCF Range Over the Past 10 Years
Min: -6.77   Med: -2.88   Max: -0.26
Current: -0.75

During the past 9 years, the highest EV-to-FCF of Chordate Medical Holding AB was -0.26. The lowest was -6.77. And the median was -2.88.

OSTO:CMH's EV-to-FCF is ranked worse than
100% of 362 companies
in the Medical Devices & Instruments industry
Industry Median: 27.855 vs OSTO:CMH: -0.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Chordate Medical Holding AB's stock price is kr0.064. Chordate Medical Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.099. Therefore, Chordate Medical Holding AB's PE Ratio for today is At Loss.


Chordate Medical Holding AB EV-to-FCF Historical Data

The historical data trend for Chordate Medical Holding AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB EV-to-FCF Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only - - - -3.52 -1.01

Chordate Medical Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.52 -3.47 -2.98 -2.10 -1.01

Competitive Comparison of Chordate Medical Holding AB's EV-to-FCF

For the Medical Devices subindustry, Chordate Medical Holding AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordate Medical Holding AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's EV-to-FCF falls into.



Chordate Medical Holding AB EV-to-FCF Calculation

Chordate Medical Holding AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=22.782/-28.411
=-0.80

Chordate Medical Holding AB's current Enterprise Value is kr22.78 Mil.
Chordate Medical Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-28.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB  (OSTO:CMH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Chordate Medical Holding AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.064/-0.099
=At Loss

Chordate Medical Holding AB's share price for today is kr0.064.
Chordate Medical Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.099.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Chordate Medical Holding AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordate Medical Holding AB (OSTO:CMH) Business Description

Traded in Other Exchanges
Address
c/o Regus, Kistagangen 20B, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines